In her latest bid to address prescription drug prices, U.S. Sen. Elizabeth Warren (D-Mass.) is urging the U.S. Federal Trade Commission to “closely scrutinize”
Tag - drug pricing
Two congressional committees recently released damning results of an 18-month investigation into the Food and Drug Administration’s approval of Biogen’s
The latest Alzheimer’s disease treatment from Eisai and Biogen needs to be cheaper than $20,000 a year to be cost-effective, according to a draft analysis from
STAT+: J&J wins a partial appeal against the U.K.’s cost-effectiveness watchdog over ‘unfair’ review
In an unusual turn of events, an appeals panel ruled that the U.K.’s cost effectiveness watchdog agency acted unfairly and exceeded its authority by failing to
For only the second time, Pfizer is offering a warranty for a medicine that will cover the cost for any patient or health plan if the medication fails to work
Mark Cuban’s drug company started with an ambitious premise: to circumvent middlemen to offer cheaper costs to patients. To do so, the company has had to
After years of squabbling, Mallinckrodt agreed to pay $260 million to settle accusations that it deliberately underpaid hundreds of millions of dollars in
In an unconventional bid to widen access to insulin for Americans, a nonprofit announced plans Thursday to make and distribute the life-saving diabetes
Public debate over legislation to allow Medicare to negotiate the price of drugs has been dominated by stories of personal suffering caused by high drug
WASHINGTON — House Democrats Friday broke a monthslong logjam and advanced prescription drug pricing reform policies as part of a broader domestic spending
